I-Mab Co-founds a SPAC: What's Up With That?
Key Takeaways:
Vivere Lifesciences Acquisition Corp., whose co-founders include U.S.-listed I-Mab, could become the first Hong Kong SPAC backed by a U.S.-listed Chinese company
The SPAC is targeting Chinese or multinational companies with Chinese operations in the health sector
By Fai Pui
Benzinga ·
Benzinga
